Jenburkt Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

136.75

123.98

109.29

118.89

122.64

Operating profit

30.37

27.26

19.84

19.74

24.96

Interest

0.37

0.43

0.47

0.53

0.39

Gross profit

35.12

31.77

23.68

23.44

27.99

EPS (Rs)

55.76

48.58

35.96

32.40

43.14

Other income

5.12

4.95

4.31

4.22

3.41

Stock adjustment

1.34

-2.28

3.18

-0.49

-2.49

Raw material

11.12

11.74

6.78

9.65

11.84

Power and fuel

-

-

-

-

-

Employee expenses

38.81

36.49

32.38

36.51

31.20

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

55.12

50.78

47.11

53.47

57.13

Provisions made

-

-

-

-

-

Depreciation

2.26

1.90

2.04

2.30

1.35

Taxation

8.26

7.57

5.14

6.27

6.84

Net profit / loss

24.61

22.30

16.50

14.87

19.80

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

4.41

4.59

4.59

4.59

4.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

22.21

21.98

18.15

16.61

20.35

GPM (%)

24.76

24.64

20.84

19.04

22.20

NPM (%)

17.34

17.29

14.53

12.08

15.71